Key result
In haemodialysed patients, abnormal cardiac sympathetic nervous system function was associated with a significantly longer median duration of haemodialysis treatment (53 months vs 12 months, p=0.03).
Why the study?
Does duration of haemodialysis affect cardiac sympathetic nervous system function in non-diabetic male patients?
Cross-Sectional (n=36)
No
Does duration of haemodialysis affect cardiac sympathetic nervous system function in non-diabetic male patients?
Longer duration of haemodialysis is associated with impaired cardiac sympathetic nervous system function in non-diabetic patients, as evidenced by reduced 123I-mIBG myocardial uptake.
Longer haemodialysis duration was associated with sympathetic dysfunction; hypothesis-generating and should not yet change practice.
BACKGROUND: The aim of this study was to evaluate the cardiac sympathetic nervous system function in haemodialysed(HD), non-diabetic patients by iodine-123 meta-iodo-benzylguanidine(123I-mIBG). MATERIALS AND METHODS: Planar scintigraphy of the chest was performed in 36 HD, male patients; 15 minutes and 4 hours post injection of 370 MBq of 123I-mIBG. The semi quantitative analysis of myocardial tracer uptake was expressed as routine heart to mediastinum (H/M) ratio: 15 minutes (early H/M) and 4 hour (late H/M) post administration as well as washout of the tracer from myocardium (WR). 24-hour Holter studies were recorded and heart rate variability (HRV) was evaluated. Patients were divided into two groups according to the H/M value: group A patients with H/M > 1.8 which has been accepted as a norm,and group B patients with H/M < 1.8. RESULTS: In 21/36 patients H/M ratio was below normal values.Significant differences between groups A and B were found among the following parameters: early H/M and late H/M ratios,WR and duration of haemodialysis therapy. CONCLUSIONS: In patients with abnormal function of cardiac sympathetic nervous system, expressed by means of H/M ratio below 1.8, duration of haemodialysis treatment was longer.Duration of HD appears to be an important factor influencing cardiac sympathetic nervous system.
No takes yet. Share an insight, caveat, or question.
Chrapko et al. (2012) conducted a cross-sectional in End-stage renal disease on haemodialysis (n=36). Abnormal cardiac sympathetic nervous system function (H/M ratio < 1.8) vs. Normal cardiac sympathetic nervous system function (H/M ratio > 1.8) was evaluated on Duration of haemodialysis therapy (months) (p=0.03). In haemodialysed patients, abnormal cardiac sympathetic nervous system function was associated with a significantly longer median duration of haemodialysis treatment (53 months vs 12 months, p=0.03).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: